Browse site A – Z

Your views

Your Views

Your feedback is vital to us as we continue to increase the quality of our services.

Your views

You are here:

Date: 30 June 2024

Time: 20:27

Queen Elizabeth Hospital Birmingham

The National 100k Genome Project: workshop

Story posted/last updated: 24 November 2014

Overview

Announcing an event to outline the West Midlands’ role in the National 100k Genome Project, which will provide whole genome sequencing on 100,000 patients with rare diseases and cancer across England.

Date Thursday 4 December
Time 16:00 and 18:00
Venue Lecture Theatre, Postgraduate Centre, Queen Elizabeth Hospital Birmingham
  • An introduction to genomics and the potential for improved patient care
  • Genomic testing in the 100,000 Genomes Project: project aims, recruitment and delivery
  • The implications of genomic results: communication and counselling
  • Familial, ethical and psychosocial considerations.

Back to top

Letter from Professor Dion Morton

Dear Colleague,

We would like to invite you and your colleagues to a workshop to outline the West Midlands’ role in the National 100k Genome Project, which will provide whole genome sequencing on 100,000 patients with rare diseases and cancer across England. The project, which is due to be launched in February 2015, provides an unprecedented opportunity for improved diagnosis and management for these conditions, as well as enhancing opportunities for research and the development of treatments. The West Midlands Genomics Medicine Centre (GMC) will be a world-leading centre for the use of genomics and genetic technologies for participant benefit within the NHS. Integral to this and the adoption of the complete functional genomics pathway – from genome sequencing and DNA, through to products such as metabolites and biomarkers – will be the development of new capability and capacity for genomic medicine within the NHS and the transformation of care delivery.

As part of the pathway to becoming a GMC we are developing a series of training sessions and workshops. The first, on 4 December 2014, will provide an overview of the 100k Genome Project and the approach that the West Midlands GMC is adopting. It will facilitate an informed dialogue and will enable clinical and non-clinical staff to raise any issues or concerns and to comment on our pilot plan.

The on-going programme of training will be covered in more detail on the day but in outline will be designed to cover:

  • an introduction to genomics and the potential for improved patient care
  • genomic testing in the 100,000 Genomes Project: project aims, recruitment and delivery
  • the implications of genomic results: communication and counselling
  • familial, ethical and psychosocial considerations

The workshop will take place on Thursday December between 16:00 and 18:00, in the Lecture Theatre at the Postgraduate Centre, QEHB. Future sessions:

  • 21/22 January 2015 – for clinical nurse specialists, consultants and research nurses: "100k Genome Project: consent, ethics and genomic counselling"
  • 29 January 2015 – "100,000 Genome Project: presenting the opportunity to patients"
  • 4/5 March 2015 – for clinical nurse specialists, consultants and research nurses: "100k Genome Project: consent, ethics and genomic counselling"

We look forward to your contribution and ideas in taking forward this exciting opportunity.

We look forward to seeing you there.

Professor Dion Morton

Back to top

Register to attend

Back to top

Getting Here

Getting here

Information about travelling to, staying at and getting around the hospital.

Getting to the hospital

Jobs at UHB

Jobs at UHB

A great place to work. Learn why.

Jobs at UHB

news@UHB

news@UHB, the newsletter for patients, staff, visitors and volunteers at University Hospitals Birmingham NHS Foundation Trust

Read news@UHB

RSS

RSS feed

Subscribe to our news feed

View our RSS

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.